Dec 03 2009
Sulfonylureas Linked to Higher Risks of Death and Heart Failure (CME/CE)
Sulfonylurea monotherapy for type 2 diabetes was associated with increased risks of all-cause death and congestive heart failure compared with metformin, a large, retrospective study showed.
Comments Off